Purpose: Transradial approach (TRA) has become increasingly common for coronary angiography and intervention (CA/PCI) and a wealth of knowledge exists about its feasibility. Nevertheless radial injury and occlusion do occur and little is known about the success rate with its repeated use. Evidence of a long lasting use of the TRA might encourage a shift toward this access route. We aimed to evaluate the feasibility of a second TRA its predictors of failure. Methods: In a dual centre prospective registry, patients who underwent a first procedure by right TRA were identified. Whenever a second coronary angiography was necessary during follow-up, and the interventionalist's clinical assessment was favourable, the right TRA was again used. We compared the rates of crossover to another access and sought predictors of crossover. Results: From January 2009 to October 2012, 6392 patients (median age 66, interquartile range 16; 67% male; 37% due to ACS) who underwent a first procedure (36% PCI) by right TRA were identified; the crossover rate to another access was 5.8%. During the study period, a second TRA was performed in 686 of these patients in whom the interventionalist's clinical assessment was favourable; the crossover rate to another access was 6.9% and similar to the first TRA (Chisquare p=0.267). Three independent predictors of failure in the latter group were identified by binary logistic regression, with the following adjusted odds-ratio (95% confidence interval): female sex 3.67 (1.98-6.8), use of 10 cm (vs. 25 cm) introducer sheath 3.52 (1.73-7.16) and previous valvular surgery 3.02 (1. 06-8.61). No differences with statistical significance were observed regarding advanced age, low body surface area, need for intervention or smaller sheath diameter. Conclusions: A second transradial approach is as feasible as the first. The use of shorter sheaths, female sex and previous valvular surgery patients reduce success in subsequent radial access.
Aims: Admission hyperglycemia is a frequent condition in ST elevation myocardial infarction (STEMI) associated with an increased risk of contrast induced nephropathy (CIN)after primary percutaneous coronary intervention (pPCI). We evaluate the possible different role of acute and chronic hyperglycemia on CIN and the impact of its early spontaneous or pharmacologic normalization. Methods and results: 679 STEMI patients treated with pPCI were enrolled in our prospective study. CIN was defined as an absolute serum creatinine increase ≥0.3 mg/dl after procedure. Admission hyperglycemia was defined as glucose levels >198 mg/dl: acute or chronic increase was identified respectivelyin patients with a glycated haemoglobin A1c ≤7% and >7%.In hyperglicemic patients, a decrease of fasting glucose levels <140 mg/dl in second day was considered for early normalization. Admission hyperglycemia (17%) was an independent predictor for CIN incidence, but at subgroup analysis its prognostic impact emerged only in non diabetic patients. Similarly, only in this subgroup its rapid normalization was associated to a lower incidence of CIN and to a better outcome. Actually, CIN incidence was significantly higher in patients with acute hyperglycemia than in those with chronic hyperglycemia (34.5% vs 16.9%, p=0.03), irrespective of diabetes mellitus. Conclusions: Admission hyperglycemia relates to an increase risk of CIN, especially when it occurs acutely. A condition ofglycemic levels ≥198 mg/dl and glycated haemoglobin A1c ≤7%, identifies patients at higher risk, in whom a rapid glycemic control could become a further strategy of CIN prevention.
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Predictors and incidence of stent edge dissections in patients with type 2 diabetes as determined by optical coherence tomography S. Reith, S. Battermann, R. Hoffmann, N. Marx, M. Burgmaier. Med. Clinic I, University Hospital Aachen, Aachen, Germany Purpose: Patients with type 2 diabetes are at increased risk for post-PCI complications including stent thrombosis and restenosis. Stent Edge Dissections (SEDs) have been associated with these complications. This study assessed incidence and predictors of SEDs in patients with type 2 diabetes using Optical Coherence Tomography (OCT). Methods: Intravascular lesion parameters and plaque morphology were investigated pre-and post-PCI using OCT in 73 type 2 diabetic patients with 90 lesions and 166 visible stent edges. Results: We detected 42 (25.3%) SEDs in 166 stent edges and 37 (41.1%) SEDs in 90 lesions. More SEDs occurred if the border of the stent had been placed within diseased vessel segments with predominantly fibrous (42.9%) and fibrocalcific (40.5%) plaques compared to healthy vessel wall morphology (p<0.001). Furthermore, the lumen eccentricity of the stent at its edges (SAE) (16.00±6.07% vs 13.11±5.22%, p<0.003) and the stent-edge-to-lumen-area-ratio (1.26±0.27 vs 0.99±0.20, p<0.001) were both significantly larger in the presence of SEDs. All of the above parameters were significant predictors for SEDs on uni-and multivariate logistic regression analysis (all p<0.01), suggesting that the lumen eccentricity of the SAE, the stent-edge-to-lumen-area-ratio and diseased vessel wall morphology of the reference segment adjacent to the stent edge are independent risk factors for the presence of SEDs. Conclusion: These results suggest that diseased vessel wall morphology at the stent edges may promote the occurrence of SEDs and that avoidance of longitudinal and transverse mismatch between stent and vessel could be important to reduce SEDs in cardiovascular high-risk patients with type 2 diabetes.
